Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 Inhibitor

Browse by: Sort by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 6 of 6
Welcome and Introduction
Sergio Fazio, MD, PhD
Oregon Health & Science University, Portland, OR
from Ancillary Symposia 2019 on March 25, 2019 5:45 PM-8:15 PM
PCSK9 and The LDL-Receptor: Understanding the Biology
Sergio Fazio, MD, PhD
Oregon Health and Science University, Portland, OR
from Ancillary Symposia 2019 on March 25, 2019 5:45 PM-8:15 PM
Patient Presentation
Keith Ferdinand, MD
Tulane University, New Orleans, LA
Don Davidson
New Orleans, LA
from Ancillary Symposia 2019 on March 25, 2019 5:45 PM-8:15 PM
The Role of PCSK9 Inhibition in Cardiovascular Risk Reduction
Savitha Subramanian, MD
University of Washington, Seattle, WA
from Ancillary Symposia 2019 on March 25, 2019 5:45 PM-8:15 PM
Who Needs Additional Lipid Lowering Drugs? - Finding the Right Patient
Eliot A Brinton, MD
Utah Lipid Center, Salt Lake City, UT
from Ancillary Symposia 2019 on March 25, 2019 5:45 PM-8:15 PM
Panel Discussion and Audience Response Questions and Closing
from Ancillary Symposia 2019 on March 25, 2019 5:45 PM-8:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 6 of 6